These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38116403)

  • 21. Age, size, and lead factors alone do not predict venous obstruction in children and young adults with transvenous lead systems.
    Bar-Cohen Y; Berul CI; Alexander ME; Fortescue EB; Walsh EP; Triedman JK; Cecchin F
    J Cardiovasc Electrophysiol; 2006 Jul; 17(7):754-9. PubMed ID: 16836673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term incidence of upper extremity venous obstruction in implantable cardioverter defibrillator patients.
    Horlbeck FW; Eckerth C; Linhart M; Schaefer C; Jakob M; Pingel S; Klarmann-Schulz U; Nickenig G; Schwab JO
    Pacing Clin Electrophysiol; 2021 Jun; 44(6):1027-1032. PubMed ID: 33974720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence of venous anatomic variants and occlusion among patients undergoing implantation of transvenous leads.
    Oginosawa Y; Abe H; Nakashima Y
    Pacing Clin Electrophysiol; 2005 May; 28(5):425-8. PubMed ID: 15869675
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transvenous cardiac implantable electronic device implantation in patients with persistent left superior vena cava in a tertiary center.
    Chen X; Yu Z; Bai J; Wang W; Qin S; Wang J; Sun Z; Han F; Su Y; Ge J
    J Interv Card Electrophysiol; 2018 Nov; 53(2):255-262. PubMed ID: 29740728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of central venous occlusion in patients with chronic defibrillator leads.
    Sticherling C; Chough SP; Baker RL; Wasmer K; Oral H; Tada H; Horwood L; Kim MH; Pelosi F; Michaud GF; Strickberger SA; Morady F; Knight BP
    Am Heart J; 2001 May; 141(5):813-6. PubMed ID: 11320371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venous Stenosis After Transvenous Lead Placement: A Study of Outcomes and Risk Factors in 212 Consecutive Patients.
    Abu-El-Haija B; Bhave PD; Campbell DN; Mazur A; Hodgson-Zingman DM; Cotarlan V; Giudici MC
    J Am Heart Assoc; 2015 Jul; 4(8):e001878. PubMed ID: 26231843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of asymptomatic upper extremity venous obstruction in 302 patients undergoing first implantation of cardioverter defibrillator.
    Linhart M; Schwab JO; Bellmann B; Schrickel JW; Kreuz J; Balta O; Naehle CP; Strach K; Schneider C; Esmailzadeh B; Fimmers R; Nickenig G; Lickfett LM
    Pacing Clin Electrophysiol; 2011 Jun; 34(6):684-9. PubMed ID: 21303390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The evaluation of the ventricular arrhythmias and interventions of cardiac implantable electronic devices in patients with dilated cardiomyopathy for primary prevention of sudden cardiac death in ambulatory and telemetric follow-up].
    Lelakowski J; Rydlewska A; Lelakowska M; Pudło J; Piekarz J
    Pol Merkur Lekarski; 2017 Jan; 42(247):13-20. PubMed ID: 28134226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fusion cardiac resynchronization therapy in an left ventricular assist device patient from two devices and crossing leads: a case report.
    Egorova AD; van Erven L; Beeres SLMA; Tops LF
    Eur Heart J Case Rep; 2021 Sep; 5(9):ytab335. PubMed ID: 34671715
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Arrhythmia, device interventions and mortality analysis in patients with implanted cardioverter-defibrillator with/without resynchronisation therapy in dilative cardiomyopathy in primary prevention of sudden cardiac death].
    Lelakowski J; Pudło J; Lelakowska-Pieła M; Rydlewska A; Piekarz J; Domaracki D
    Pol Merkur Lekarski; 2016 Apr; 40(238):216-22. PubMed ID: 27137820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Planning and guidance of cardiac resynchronization therapy-lead implantation by evaluating coronary venous anatomy assessed with multidetector computed tomography.
    Catanzaro JN; Makaryus JN; Jadonath R; Makaryus AN
    Clin Med Insights Cardiol; 2014; 8(Suppl 4):43-50. PubMed ID: 25995655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upper Extremity Deep Vein Thrombosis and Asymptomatic Vein Occlusion in Patients With Transvenous Leads: A Systematic Review and Meta-Analysis.
    Duijzer D; de Winter MA; Nijkeuter M; Tuinenburg AE; Westerink J
    Front Cardiovasc Med; 2021; 8():698336. PubMed ID: 34490367
    [No Abstract]   [Full Text] [Related]  

  • 34. Pacemaker implantation in superior vena cava obstruction: Re-canalization, venoplasty, and stenting.
    Thomas DE; Phan TT; Hartley R; Linker NJ; Muir DF; Turley AJ
    J Cardiol Cases; 2016 Jul; 14(1):29-31. PubMed ID: 30546655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spontaneous subclavian venous occlusion before electronic device implantation.
    Kodani T; Mine T; Kishima H; Ashida K; Masuyama T
    Asian Cardiovasc Thorac Ann; 2015 Jun; 23(5):530-4. PubMed ID: 25614481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Venous thrombosis and stenosis after implantation of pacemakers and defibrillators.
    Rozmus G; Daubert JP; Huang DT; Rosero S; Hall B; Francis C
    J Interv Card Electrophysiol; 2005 Jun; 13(1):9-19. PubMed ID: 15976973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute and Long-Term Outcomes of Transvenous Cardiac Pacing Device Implantation in Patients With Congenital Heart Disease.
    Takeuchi D; Toyohara K; Yagishita D; Yazaki K; Higuchi S; Ejima K; Shoda M; Hagiwara N
    Circ Rep; 2019 Sep; 1(10):445-455. PubMed ID: 33693082
    [No Abstract]   [Full Text] [Related]  

  • 38. Axillary vein spasm during cardiac implantable electronic device implantation.
    Steckiewicz R; Górko D; Świętoń EB; Szparecki G; Stolarz P
    Folia Morphol (Warsz); 2016; 75(4):543-549. PubMed ID: 27830883
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stent dilation of superior vena cava and innominate vein obstructions permits transvenous pacing lead implantation.
    Ing FF; Mullins CE; Grifka RG; Nihill MR; Fenrich AL; Collins EL; Friedman RA
    Pacing Clin Electrophysiol; 1998 Aug; 21(8):1517-30. PubMed ID: 9725149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of superior vena cava anomalies as detected in cardiac implantable electronic device recipients at a tertiary cardiology centre over a 12-year period.
    Steckiewicz R; Kosior DA; Rosiak M; Świętoń E; Stolarz P; Grabowski M
    Hellenic J Cardiol; 2016; 57(2):101-6. PubMed ID: 27445024
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.